I hope 2016 was a wonderful year for you. It certainly was for us here at Chris O’Brien Lifehouse.
Last year we treated more than 17,000 patients and either ran or participated in more than 300 clinical trials and research projects. Some of these trials, such as the world’s biggest clinical trial of medical cannabis, sought to improve the quality of life for our patients. Others, such as for the drug, Keytruda, are saving lives right now.
Meanwhile, our da Vinci Xi Surgical System (the Robot) completed its 100th operation. As you might be aware, the Robot is one of the world’s most advanced pieces of medical hardware and allows our surgeons to conduct minimally invasive surgery as well as enabling our senior staff to teach robotics to the next generation.
Already 2017 is off to a flying start. In line with our ethos of putting the patient at the heart of what we do, Lifehouse Director Gail O’Brien began her new role as Patient Advocate. In this position, Gail will bring to bear her enormous amount of experience with cancer as well as her unique perspective of being a carer.
We are also excited to announce that in May, we are bringing one of the world’s leading gynaecological oncologists to Lifehouse- Dr Marcelo Nascimento from Brazil. This position will allow Lifehouse to expand its tertiary ovarian cancer surgical capabilities and offer new hope to patients who have recently come out of remission.
And finally, I would like to thank everyone who took part in our 2017 Supporter Survey.
You sent us a strong message that you would like to hear more about our research and clinical trials. So I am delighted to let you know that we have just published our inaugural research report. Click here to read the full report.
In future newsletters I look forward to updating you regarding new successes and innovations as 2017 progresses. Until that time may I wish you all the best on behalf of all the staff and patients at Chris O’Brien Lifehouse and thank you as always for your support.